Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.
Br J Anaesth
; 113(1): 194-5, 2014 Jul.
Article
in En
| MEDLINE
| ID: mdl-24942721
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Resuscitation
/
Hydroxyethyl Starch Derivatives
/
Plasma Substitutes
/
Fluid Therapy
Limits:
Humans
Language:
En
Journal:
Br J Anaesth
Year:
2014
Document type:
Article